Norbudrine (INN ; developmental code name RD-9338), also known as norbutrine (BAN ) or as N-cyclobutylnoradrenaline, is a drug of the phenethylamine and catecholamine families described as a sympathomimetic and bronchodilator which was never marketed.[1][2][3] It is the N-cyclobutyl analogue of norepinephrine (noradrenaline).[1][4] The drug was first described in the literature by 1966.[1]
Clinical data | |
---|---|
Other names | Norbutrine; RD-9338; N-Cyclobutylnoradrenaline; N-Cyclobutylnorepinephrine |
Drug class | Sympathomimetic; Bronchodilator |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H17NO3 |
Molar mass | 223.272 g·mol−1 |
3D model (JSmol) | |
| |
|
References
edit- ^ a b c Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 1-PA215. ISBN 978-1-4757-2085-3. Retrieved 17 October 2024.
- ^ List PH, Hörhammer L (2013). Chemikalien und Drogen Teil A: N-Q. Handbuch der Pharmazeutischen Praxis - Vollständige (4.) Neuausgabe (in German). Springer Berlin Heidelberg. pp. 265–266. ISBN 978-3-642-65035-2. Retrieved 17 October 2024.
- ^ "-drine sympathomimetics" (PDF). The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2018 (Stem Book 2018). World Health Organization.
- ^ "Norbudrine". PubChem. U.S. National Library of Medicine. Retrieved 17 October 2024.